Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Bacteria or actinomycetales
Reexamination Certificate
2007-05-15
2007-05-15
Afremova, Vera (Department: 1657)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Bacteria or actinomycetales
C424S009100, C435S252500, C435S853000
Reexamination Certificate
active
10247841
ABSTRACT:
The present invention relates to the use of lactic acid bacteria capable of adhering to the mucosa of the intestine and especially colonizing it for the prevention of peritonitis. In particular, the present invention relates to the use of such lactic acid bacteria for the prevention of peritonitis caused by cirrhosis of the liver. Specifically, the present invention relates to a method for preventing peritonitis in a patient in need of such prevention. This method includes administering to the patient a lactic acid bacterium that is capable of adhering to the intestine's mucosa and essentially colonizing it for the preparation of an ingestable carrier. The invention also relates to a peritonitis preventing composition of a lactic acid bacterium that is capable of adhering to the intestine's mucosa and essentially colonizing it for the preparation of an ingestable carrier. The carrier is preferably a food or pharmaceutical composition.
REFERENCES:
patent: 5494664 (1996-02-01), Brassart et al.
patent: 5603930 (1997-02-01), Brassart et al.
patent: 5716615 (1998-02-01), Cavaliere Vesely et al.
patent: 6368591 (2002-04-01), Chen et al.
patent: 6399124 (2002-06-01), Lesens et al.
patent: 0363491 (1990-04-01), None
patent: 0577904 (1994-01-01), None
patent: 861905 (1998-10-01), None
patent: 04264034 (1993-11-01), None
patent: 08176000 (1996-09-01), None
patent: 09301877 (1998-02-01), None
patent: WO 96/35440 (1996-11-01), None
patent: WO 99/07393 (1999-02-01), None
Garcia-Lafuente et al. Antiinflammatory effect ofLactobacillus paracaseion bowel inflammation. Gastroenterology, (Apr. 1999), vol. 116, No. 4, part 2, pp. A882.
Lafuente et al., XP-000961243 “Anti-inflammatory Effect OfLactobacillus paracaseiIn A Model Of Bowel Inflammation”, P. A 882 p.a.. 1999.
D. Brassart et al., XP-0009611251, “The Use Of Probiotics To Reinforce Mucosal Defence Mechanisms”, Trends in Food Science & Technology, vol. 8, pp. 321-326 (1997).
Mattila Sandholm et al., XP-000971026, “Probiotics: towards demonstrating efficacy”, Trends in Food Science & Technology, vol. 10, pp. 393-399 (1999).
English Abstract Article by F B Kasravi et al., The effect of pretreatment with endotoxin andlactobacillusonbacterial translocation in acute liver injury. Department of Surgery, Lund University, European Journal Of Surgery, vol. 162 (7), pp. 537, (1996).
English Abstract Article by T. Shiina et al., “Effects of heat treated cells of intestinal lactic acid bacteria in rats fed a deoxycholic acid diet”, Institute for Intestinal and Environmental Microbiology, Jikken Dobutsu. Experimental Animals, vol. 39 (3) pp. 325-335 (1990).
Guarner Carlos
Schiffrin Eduardo
Soriano German
Afremova Vera
Bell Boyd & Lloyd LLP
Nestec S.A.
LandOfFree
Methods of preventing peritonitis by administering lactic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of preventing peritonitis by administering lactic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of preventing peritonitis by administering lactic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3772673